Microbicides
Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa
Williams BG, Abdool Karim SS, Karim QA, Gouws E. J Acquir Immune Defic Syndr. 2011 Jun 7. [Epub ahead of print]
Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa
Williams BG, Abdool Karim SS, Karim QA, Gouws E. J Acquir Immune Defic Syndr. 2011 Jun 7. [Epub ahead of print]
Turning the tide against HIV
Shattock RJ, Warren M, McCormack S, Hankins CA. Science. 2011;333(6038):42-3.
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection
Li L, Tan S, Lu H, Lu L, Yang J, Jin H, Liu S, Jiang S. J Acquir Immune Defic Syndr. 2011 Jan 13
Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda
Johnson KE, Redd AD, Quinn TC, Collinson-Streng AN, Cornish T, Kong X, Sharma R, Tobian AA, Tsai B, Sherman ME, Kigozi G, Serwadda D, Wawer MJ, Gray RH. J Infect Dis. 2011 Mar;203(5):602-9
Exploring the condom gap: is supply or demand the limiting factor? – Condom access and use in an urban and a rural setting in Kilifi district, Kenya
Papo JK, Bauni EK, Sanders EJ, Brocklehurst P, Jaffe HW. AIDS. 2011 Jan 14;25(2):247-55
Apples and oranges? Interpreting success in HIV prevention trials
Heise LL, Watts C, Foss A, Trussell J, Vickerman P, Hayes R, McCormack S. Contraception. 2011 Jan;83(1):10-5
The challenge of defining standards of prevention in HIV prevention trials
Philpott S, Heise L, McGrory E, Paxton L, Hankins C; the participants in the 2009 GCM/CDC/UNAIDS Consultation on Standards of Prevention in HIV Prevention Trials. J Med Ethics. 2010 Dec 24
Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: development of dual-protection technologies
Friend DR, Doncel GF. Antiviral Res. 2010 Dec;88 Suppl 1:S47-54
Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model
Neff CP, Ndolo T, Tandon A, Habu Y, Akkina R. PLoS One. 2010 Dec 21;5(12):e15257